ABEMX
Price
$20.62
Change
+$0.43 (+2.13%)
Updated
Jul 31 closing price
Net Assets
1.02B
FNWFX
Price
$106.35
Change
+$2.06 (+1.98%)
Updated
Jul 31 closing price
Net Assets
90.71B
Interact to see
Advertisement

ABEMX vs FNWFX

ABEMX vs FNWFX Comparison Chart in %
View a ticker or compare two or three
VS
ABEMX vs. FNWFX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABEMX is a Hold and FNWFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FNWFX has more cash in the bank: 90.7B vs. ABEMX (1.02B). FNWFX pays higher dividends than ABEMX: FNWFX (1.27) vs ABEMX (0.71). ABEMX was incepted earlier than FNWFX: ABEMX (19 years) vs FNWFX (10 years). ABEMX (1.20) is less costly to investors than FNWFX (0.57). FNWFX is a more actively managed with annual turnover of: 46.00 vs. ABEMX (35.00). ABEMX (1000000) and FNWFX (1000000) have matching initial minimum investment requirements. ABEMX annual gain was more profitable for investors over the last year : 35.34 vs. FNWFX (22.02). FNWFX return over 5 years is better than : 18.79 vs. ABEMX (6.66).
ABEMXFNWFXABEMX / FNWFX
Total Expense Ratio1.100.57193%
Annual Report Gross Expense Ratio1.200.57211%
Fund Existence19 years10 years-
Gain YTD22.37414.073159%
Front LoadN/AN/A-
Min. Initial Investment10000001000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.02B90.7B1%
Annual Yield % from dividends0.711.2756%
Returns for 1 year35.3422.02160%
Returns for 3 years56.8545.21126%
Returns for 5 years6.6618.7935%
Returns for 10 years74.23N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICISX17.540.03
+0.17%
VY® Columbia Small Cp Val & Inflection I
JRBFX34.650.05
+0.14%
JHancock Regional Bank I
TSMNX19.09-0.08
-0.42%
Nuveen Quant Small/Mid Cap Eq I
DFIVX32.87-0.20
-0.60%
DFA International Value I
SNIEX18.30-0.15
-0.81%
BNY Mellon International Equity I